Abstract Abstract 1892 Background: Primary or light chain amyloidosis (AL) is a clonal
plasma cell disorder characterized by a relatively low plasma cell burden and multi-organ …

Background Light chain (AL) amyloidosis is a rare, complex disease associated with
significant morbidity and mortality. Delays in diagnosis are common and may have …

Amyloidosis is a disease in which abnormal proteins form toxic intermediates and fibrillar
tissue-deposits that compromise key viscera and lead to early death. In order to treat …

Abstract Abstract 3401 Poster Board III-289 Introduction: Systemic amyloid light chain
amyloidosis (AL) is a fatal monoclonal plasma cell disorder which leads to depositions of …

Light chain (AL) amyloidosis is a form of systemic amyloidosis, causing organ dysfunction,
mainly affecting the heart and kidney. Patient-tailored and risk-adapted decision making is …

Background Treatment of AL amyloidosis (AL) has typically followed the treatment patterns
used in myeloma, but has changed in a disease specific manner during the past few years …

AL amyloidosis is the most common systemic amyloidoses. In this disorder, clonal plasma
cells or B cells produce monoclonal immunoglobulin free light chains that misfold …

Background Systemic immunoglobulin light-chain amyloidosis (AL) is a plasma cell
dyscrasia resulting in multisystem organ failure and death. Autologous hematopoietic stem …

Objective To study the impact of time to diagnosis on cardiac Mayo stages, treatment
outcome, and overall survival. Methods We retrospectively analyzed 77 consecutive patients …

Systemic Light chain (AL) amyloidosis is a monoclonal plasma cell proliferative disorder
characterized by deposition of amyloidogenic monoclonal light chain fragments causing …